Medium Calorie Parenteral Nutrition on Patients With Gastrointestinal Cancer Undergoing Surgery
Assessment the Effect of Medium-Calorie TPN on Patients With Gastrointestinal Cancer Undergoing Surgery
1 other identifier
interventional
40
1 country
1
Brief Summary
aimed at investigating the efficacy, safety, and clinical outcome of Medium-Calorie or standard-calorie total parenteral nutrition (TPN) for patients with gastrointestinal cancer undergoing surgery
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Apr 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 2, 2012
CompletedFirst Posted
Study publicly available on registry
October 4, 2012
CompletedOctober 4, 2012
October 1, 2012
1.6 years
October 2, 2012
October 2, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
biochemistry data; Various inflammation-related cytokines ;
7 days
Secondary Outcomes (1)
clinical outcome(hospital stay..)
2 months
Study Arms (2)
Medium calorie
EXPERIMENTALstandard calorie
EXPERIMENTALInterventions
Medium calorie ,Nonprotein calories 20 Kcal/Kg/day,Protein 1g/Kg,Fat emulsion 0.5 g/kg/day D1-D6 post OP standard calorie, Nonprotein calories 30 Kcal/Kg/day,Protein 1.5 g/Kg,Fat emulsion 50g/day D1-D6 post OP
Eligibility Criteria
You may qualify if:
- Patients considered for major surgery for colorectal cancer Expected requirement for post operative PN or TPN of at least for 7 days Age \>18 Hemodynamically stable Written Informed Consent
You may not qualify if:
- Hemodynamic failure of any organ Renal insufficiency Patients with severe liver dysfunction Albumin \< 3g/dL DM with poor blood sugar control
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Medical University Hospital
Kaohsiung City, Kaohsiung, 80756, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
JF CHUANG, M.S.
Department of pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
- STUDY CHAIR
JY WANG, M.D.
Departments of Surgery Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
- STUDY DIRECTOR
YB HUANG, Ph.D.
Departments of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of pharmacy, leader
Study Record Dates
First Submitted
October 2, 2012
First Posted
October 4, 2012
Study Start
April 1, 2007
Primary Completion
November 1, 2008
Study Completion
December 1, 2008
Last Updated
October 4, 2012
Record last verified: 2012-10